Source:http://linkedlifedata.com/resource/pubmed/id/10593481
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4-5
|
pubmed:dateCreated |
1999-12-22
|
pubmed:abstractText |
The chemokine receptor CCR5 is known to be a critical determinant of human immunodeficiency virus (HIV) transmission and pathogenesis in the human host. Towards the development of a macaque model to evaluate the efficacy of vaccines and therapeutics against infection with CCR5-specific viruses, and to delineate the pathogenic properties of such viruses, we constructed a chimeric simian human immunodeficiency virus, SHIV(SF162), containing the env, tat, rev, and vpu genes from HIV-1(SF162) (R5, MT/NSI) in the context of the molecular clone simian immunodeficiency virus, SIV(mac239). Virus generated from this molecular clone was used to intravenously infect two juvenile macaques, followed by three consecutive serial blood/bone marrow transfusions. Animals infected with parental SHIV(SF162) (P1) had detectable levels of viral replication (as determined by p27(gag) production) within days of infection; however, viral set-points fell below detection by Week 3. Late passage animals (P3 and P4) had a two-log increase in the level of plasma p27(gag) antigen. These results demonstrate that in vivo serial passage of the R5-specific SHIV(SF162) enhanced its replicative capacity.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/AIDS Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CCR5,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Chemokine,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Envelope Proteins
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0047-2565
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
164-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10593481-AIDS Vaccines,
pubmed-meshheading:10593481-Animals,
pubmed-meshheading:10593481-Antigens, Viral,
pubmed-meshheading:10593481-CD4 Lymphocyte Count,
pubmed-meshheading:10593481-CD4-CD8 Ratio,
pubmed-meshheading:10593481-Chimera,
pubmed-meshheading:10593481-Disease Models, Animal,
pubmed-meshheading:10593481-Humans,
pubmed-meshheading:10593481-Macaca mulatta,
pubmed-meshheading:10593481-Receptors, CCR5,
pubmed-meshheading:10593481-Receptors, Chemokine,
pubmed-meshheading:10593481-Simian Acquired Immunodeficiency Syndrome,
pubmed-meshheading:10593481-Simian immunodeficiency virus,
pubmed-meshheading:10593481-Viral Envelope Proteins
|
pubmed:articleTitle |
In vivo adaptation of SHIV(SF162): chimeric virus expressing a NSI, CCR5-specific envelope protein.
|
pubmed:affiliation |
Aaron Diamond AIDS Research Center, The Rockefeller University, New York, NY 10016, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|